ARTICLE | Company News
Atlantic, Genzyme Transgenics deal
February 20, 2001 8:00 AM UTC
GZTC will develop transgenic goats to produce Atlantic’s ABI.001 recombinant human protein, a selective immune suppressor to treat myasthenia gravis. Atlantic expects to begin clinical testing of ABI....